Literature DB >> 18411301

The TSC1-TSC2 complex is required for proper activation of mTOR complex 2.

Jingxiang Huang1, Christian C Dibble, Mika Matsuzaki, Brendan D Manning.   

Abstract

The mammalian target of rapamycin (mTOR) is a protein kinase that forms two functionally distinct complexes important for nutrient and growth factor signaling. Both complexes phosphorylate a hydrophobic motif on downstream protein kinases, which contributes to the activation of these kinases. mTOR complex 1 (mTORC1) phosphorylates S6K1, while mTORC2 phosphorylates Akt. The TSC1-TSC2 complex is a critical negative regulator of mTORC1. However, how mTORC2 is regulated and whether the TSC1-TSC2 complex is involved are unknown. We find that mTORC2 isolated from a variety of cells lacking a functional TSC1-TSC2 complex is impaired in its kinase activity toward Akt. Importantly, the defect in mTORC2 activity in these cells can be separated from effects on mTORC1 signaling and known feedback mechanisms affecting insulin receptor substrate-1 and phosphatidylinositol 3-kinase. Our data also suggest that the TSC1-TSC2 complex positively regulates mTORC2 in a manner independent of its GTPase-activating protein activity toward Rheb. Finally, we find that the TSC1-TSC2 complex can physically associate with mTORC2 but not mTORC1. These data demonstrate that the TSC1-TSC2 complex inhibits mTORC1 and activates mTORC2, which through different mechanisms promotes Akt activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18411301      PMCID: PMC2423120          DOI: 10.1128/MCB.00289-08

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  56 in total

1.  Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.

Authors:  D D Sarbassov; David A Guertin; Siraj M Ali; David M Sabatini
Journal:  Science       Date:  2005-02-18       Impact factor: 47.728

2.  Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis.

Authors:  T Carsillo; A Astrinidis; E P Henske
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

3.  Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB.

Authors:  Dos D Sarbassov; Siraj M Ali; Shomit Sengupta; Joon-Ho Sheen; Peggy P Hsu; Alex F Bagley; Andrew L Markhard; David M Sabatini
Journal:  Mol Cell       Date:  2006-04-06       Impact factor: 17.970

4.  Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2.

Authors:  Brendan D Manning; M Nicole Logsdon; Alex I Lipovsky; Derek Abbott; David J Kwiatkowski; Lewis C Cantley
Journal:  Genes Dev       Date:  2005-07-18       Impact factor: 11.361

5.  Identification of a conserved motif required for mTOR signaling.

Authors:  Stefanie S Schalm; John Blenis
Journal:  Curr Biol       Date:  2002-04-16       Impact factor: 10.834

6.  Rheb binding to mammalian target of rapamycin (mTOR) is regulated by amino acid sufficiency.

Authors:  Xiaomeng Long; Sara Ortiz-Vega; Yenshou Lin; Joseph Avruch
Journal:  J Biol Chem       Date:  2005-05-05       Impact factor: 5.157

7.  The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination.

Authors:  G Benvenuto; S Li; S J Brown; R Braverman; W C Vass; J P Cheadle; D J Halley; J R Sampson; R Wienecke; J E DeClue
Journal:  Oncogene       Date:  2000-12-14       Impact factor: 9.867

8.  A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells.

Authors:  David J Kwiatkowski; Hongbing Zhang; Jennifer L Bandura; Kristina M Heiberger; Michael Glogauer; Nisreen el-Hashemite; Hiroaki Onda
Journal:  Hum Mol Genet       Date:  2002-03-01       Impact factor: 6.150

9.  mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery.

Authors:  Do-Hyung Kim; D D Sarbassov; Siraj M Ali; Jessie E King; Robert R Latek; Hediye Erdjument-Bromage; Paul Tempst; David M Sabatini
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

Review 10.  Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis.

Authors:  Brendan D Manning
Journal:  J Cell Biol       Date:  2004-11-08       Impact factor: 10.539

View more
  244 in total

1.  Tuberous sclerosis complex 2 (TSC2) regulates cell migration and polarity through activation of CDC42 and RAC1.

Authors:  Yan Larson; Jianyu Liu; Payton D Stevens; Xin Li; Jing Li; B Mark Evers; Tianyan Gao
Journal:  J Biol Chem       Date:  2010-06-08       Impact factor: 5.157

2.  TOR complex 2 (TORC2) in Dictyostelium suppresses phagocytic nutrient capture independently of TORC1-mediated nutrient sensing.

Authors:  Daniel Rosel; Taruna Khurana; Amit Majithia; Xiuli Huang; Ramanath Bhandari; Alan R Kimmel
Journal:  J Cell Sci       Date:  2012-01-20       Impact factor: 5.285

3.  Regulation of mast cell survival and function by tuberous sclerosis complex 1.

Authors:  Jinwook Shin; Hongjie Pan; Xiao-Ping Zhong
Journal:  Blood       Date:  2012-02-23       Impact factor: 22.113

4.  Differential IKK/NF-κB Activity Is Mediated by TSC2 through mTORC1 in PTEN-Null Prostate Cancer and Tuberous Sclerosis Complex Tumor Cells.

Authors:  Yu Gao; Ronald B Gartenhaus; Rena G Lapidus; Arif Hussain; Yanting Zhang; Xinghuan Wang; Han C Dan
Journal:  Mol Cancer Res       Date:  2015-09-15       Impact factor: 5.852

Review 5.  Stem cell guidance through the mechanistic target of rapamycin.

Authors:  Kenneth Maiese
Journal:  World J Stem Cells       Date:  2015-08-26       Impact factor: 5.326

6.  Tuberous sclerosis 1 (Tsc1)-dependent metabolic checkpoint controls development of dendritic cells.

Authors:  Yanyan Wang; Gonghua Huang; Hu Zeng; Kai Yang; Richard F Lamb; Hongbo Chi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-26       Impact factor: 11.205

7.  XPLN is an endogenous inhibitor of mTORC2.

Authors:  Nidhi Khanna; Yimin Fang; Mee-Sup Yoon; Jie Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

Review 8.  AKT/PKB Signaling: Navigating the Network.

Authors:  Brendan D Manning; Alex Toker
Journal:  Cell       Date:  2017-04-20       Impact factor: 41.582

Review 9.  A complex interplay between Akt, TSC2 and the two mTOR complexes.

Authors:  Jingxiang Huang; Brendan D Manning
Journal:  Biochem Soc Trans       Date:  2009-02       Impact factor: 5.407

Review 10.  Common corruption of the mTOR signaling network in human tumors.

Authors:  S Menon; B D Manning
Journal:  Oncogene       Date:  2008-12       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.